Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE PRINCIPALE : revenue, balance sheet and financial ratios

SELARL PHARMACIE PRINCIPALE is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PETITE-ROSSELLE (57540), this company of category PME shows in 2023 a net income positive of 277 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE PRINCIPALE (SIREN 752112664)
Indicator 2023 2021 2020 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C
Net income 277 006 € 639 976 € 214 959 € 263 253 € 272 987 € -184 075 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2023, SELARL PHARMACIE PRINCIPALE generates positive net income of 277 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

277 006 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 82%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

82.138%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

46.361%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

44.2%

Solvency indicators evolution
SELARL PHARMACIE PRINCIPALE

Sector positioning

Debt ratio
82.14 2023
2020
2021
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Average -9 pts over 3 years

In 2023, the debt ratio of SELARL PHARMACIE PRINCIPALE (82.14) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
46.36% 2023
2020
2021
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Average +11 pts over 3 years

In 2023, the financial autonomy of SELARL PHARMACIE PRINCIPALE (46.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 193.08. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

193.079

Liquidity indicators evolution
SELARL PHARMACIE PRINCIPALE

Sector positioning

Liquidity ratio
193.08 2023
2020
2021
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Good

In 2023, the liquidity ratio of SELARL PHARMACIE PRINCIPALE (193.08) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELARL PHARMACIE PRINCIPALE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2023, the value of SELARL PHARMACIE PRINCIPALE is estimated at 3 268 525 € (range 1 987 746€ - 4 594 813€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
220 transactions
1987k€ 3268k€ 4594k€
3 268 525 € Range: 1 987 746€ - 4 594 813€
NAF 5 année 2023

Valuation method used

Net Income Multiple
277 006 € × 11.8x = 3 268 526 €
Range: 1 987 747€ - 4 594 814€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE PRINCIPALE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE PRINCIPALE

What is the revenue of SELARL PHARMACIE PRINCIPALE ?

The revenue of SELARL PHARMACIE PRINCIPALE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE PRINCIPALE profitable?

Yes, SELARL PHARMACIE PRINCIPALE generated a net profit of 277 k€ in 2023.

Where is the headquarters of SELARL PHARMACIE PRINCIPALE ?

The headquarters of SELARL PHARMACIE PRINCIPALE is located in PETITE-ROSSELLE (57540), in the department Moselle.

Where to find the tax return of SELARL PHARMACIE PRINCIPALE ?

The tax return of SELARL PHARMACIE PRINCIPALE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE PRINCIPALE operate?

SELARL PHARMACIE PRINCIPALE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.